CoChat

Re-Education of Macrophages as a Therapeutic Strategy in Cancer

Open access
Kowal, Joanna, Kornete, Mara, Joyce, Johanna A · 2019 · Immunotherapy

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Abstract

Tumor-associated macrophages (TAMs) can be educated within the tumor microenvironment to promote cancer development and progression. While TAM-targeted agents have largely focused on macrophage depletion as an anticancer strategy, it is becoming increasingly evident that TAM re-education may represent a more effective approach. In this perspective, we discuss different means to achieve TAM re-education, and review the beneficial effects of these strategies, particularly when combined with immune checkpoint inhibitors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2217/imt-2018-0156

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY-NC-ND · From the PDF
Figure 1 Macrophage targeting strategies in cancer. The plasticity of macrophages and their high capacity to adapt to external signals allow cancer cells to hijack their biological functions. In the majority of solid tumors, macrophages recruited to the tumor niche are educated to acquire protumoral phenotypes. Several strategies have been developed to target macrophages in the tumor microenvironment, including their killing or re-education. Most macrophage-targeted therapies are currently focused on CSF-1R inhibitors, which either deplete or reprogram macrophages. Macrophages can also be targeted via a CD40 agonist that boosts the antitumoral response. Another approach is via disruption of macrophage-derived PD-1 and its interactions with PD-L1 on other cell types. CCL5-CCR5 blockade can result in the re-education of macrophages and subsequent tumor regression. Reprogramming of macrophages can also be achieved by either pharmacologic inhibition or genetic deletion of PI3Kgamma, Tie2, DICER or histone deacetylase class IIa, or via antibody-based targeting of the macrophage-derived protein MARCO.
Figure 1 Macrophage targeting strategies in cancer. The plasticity of macrophages and their high capacity to adapt to external signals allow cancer cells to hijack their biological functions. In the majority of solid tumors, macrophages recruited to the tumor niche are educated to acquire protumoral phenotypes. Several strategies have been developed to target macrophages in the tumor microenvironment, including their killing or re-education. Most macrophage-targeted therapies are currently focused on CSF-1R inhibitors, which either deplete or reprogram macrophages. Macrophages can also be targeted via a CD40 agonist that boosts the antitumoral response. Another approach is via disruption of macrophage-derived PD-1 and its interactions with PD-L1 on other cell types. CCL5-CCR5 blockade can result in the re-education of macrophages and subsequent tumor regression. Reprogramming of macrophages can also be achieved by either pharmacologic inhibition or genetic deletion of PI3Kgamma, Tie2, DICER or histone deacetylase class IIa, or via antibody-based targeting of the macrophage-derived protein MARCO.CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 66 references

Cited by

See all 162

Metadata

Authors
Kowal, J., Kornete, M., & Joyce, J. A.
Affiliations
Ludwig Cancer Research (CH)
Corresponding author
Joyce, Johanna A
Venue
Immunotherapy
Published
2019-05-15
Volume
11
Issue
8
Pages
677-689
ISSN
  • 1750-743X (ISSN-L)
  • 1750-7448
OpenAlex
W2945653463
Cited by
161
References
66
Citations by year
2026: 9 · 2025: 18 · 2024: 12 · 2023: 26 · 2022: 32 · 2021: 39 · 2020: 19 · 2019: 6
FWCI
9.67
Type
journal article
Language
en
Open access
Locations
  • Immunotherapy (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • SERVAL (Université de Lausanne) (publishedVersion, cc-by-nc-nd)
  • IRIS (submittedVersion, cc-by-nc-nd)
Funders
  • Swiss Cancer League
  • Swiss Bridge Award
  • Breast Cancer Research Foundation
  • Cancer Research UK, Ludwig Institute for Cancer Research, and the University of Lausanne
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
tumor-associated macrophages, tumor microenvironment, TAM-targeted therapy, macrophage depletion, immune checkpoint inhibitors, cancer immunotherapy, tumor progression
MeSH terms
Animals, Humans, Immunotherapy, Macrophages, Neoplasms, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Re-Education of Macrophages as a Therapeutic Strategy in Cancer. https://app.cochat.ai/papers/10.2217/imt-2018-0156
The paper
Kowal, J., Kornete, M., & Joyce, J. A. (2019). Re-Education of Macrophages as a Therapeutic Strategy in Cancer. Immunotherapy. https://doi.org/10.2217/imt-2018-0156

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.